Aspen Aerogels (NYSE: ASPN) reported Q2 EPS of ($0.29), $0.06 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $21.7 million versus the consensus estimate of $25.45 million.

GUIDANCE:

Aspen Aerogels sees FY2018 EPS of ($0.87)-($0.95), versus the consensus of ($0.83). Aspen Aerogels sees FY2018 revenue of $102-112 million, versus the consensus of $111.46 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.